CSGP vs ERNA · P/E 484, rev $2.74B vs P/E 0.0, rev $582.0K
CoStar Group Inc (CSGP) versus Eterna Therapeutics Inc (ERNA) — a side-by-side from cached financials, not a winner call.
CoStar Group Inc (CSGP) is a real estate services company listed on US.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Latest reported CSGP revenue for 2024-12-31 was $2.74B. Net income was $138.7M. Revenue was up 11.5% from 2023-12-31 to 2024-12-31. CSGP currently screens at market cap $13.84B and trailing P/E 484.1.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
CSGP currently screens at market cap $13.84B and trailing P/E 484.1. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Not investment advice. Open the CSGP and ERNA stock pages for the full models.
Not investment advice.